INCIDENCE AND RISK FACTORS FOR ATRIAL FIBRILLATION AND ATRIAL FLUTTER IN PATIENTS WITH MULTIPLE MYELOMA AFTER MELPHALAN CONDITIONING FOR AUTOLOGOUS STEM CELL TRANSPLANT

被引：0
|
作者：
Rim, Austin [1 ]
Graiser, Michael [1 ]
Mandawat, Anant [1 ]
机构：
[1] Emory Univ, Atlanta, GA 30322 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2021年 / 77卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3276 / 3276
页数：1
相关论文
共 50 条
  • [1] Atrial Fibrillation and Atrial Flutter in Heart Transplant Patients: Incidence, Risk Factors and Clinical Outcomes
    Dasari, T. W.
    Pavlovic-Surjancev, B.
    Patel, N.
    Williams, A. A.
    Ezidinma, P.
    Rupani, A.
    Sinacore, J. L.
    Loyala, A. L. Heroux
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (02): : S167 - S167
  • [2] Paroxysmal atrial fibrillation (AF) as a complication of autologous stem cell transplant (ASCT) with higher doses of melphalan (MEL) in multiple myeloma (MM) patients.
    Hari, P
    Thumma, S
    Bredeson, C
    Drobyski, W
    Horowitz, M
    Kovatovic, K
    Olson, L
    Johnson, VP
    Keever-Taylor, C
    Rizzo, JD
    Wade, JC
    Vesole, DH
    [J]. BLOOD, 2003, 102 (11) : 710A - 710A
  • [3] Mitoxantrone and melphalan as conditioning regimen for autologous stem cell transplant for multiple myeloma.
    Beaven, Anne W.
    Comeau, Terrance
    Sharf, Andrew
    Moore, Dominic T.
    Serody, Jonathan
    Shea, Thomas C.
    Gabriel, Don A.
    [J]. BLOOD, 2006, 108 (11) : 834A - 834A
  • [4] Incidence, Risk Factors, and Clinical Outcomes of Atrial Fibrillation and Atrial Flutter After Heart Transplantation
    Dasari, Tarun W.
    Pavlovic-Surjancev, Biljana
    Patel, Nilamkumar
    Williams, Alexis A.
    Ezidinma, Phoebe
    Rupani, Arti
    Sinacore, James L.
    Heroux, Alain L.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (05): : 737 - 741
  • [5] A PHASE I STUDY OF BENDAMUSTINE AND MELPHALAN CONDITIONING FOR AUTOLOGOUS STEM CELL TRANSPLANT IN MULTIPLE MYELOMA
    Mark, T. M.
    Niesvizky, R.
    Gergis, U.
    Pearse, R. N.
    Mayer, S.
    Feldman, E. J.
    Shore, T. B.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S199 - S199
  • [6] A Phase 1 Study of Bendamustine and Melphalan Conditioning for Autologous Stem Cell Transplant in Multiple Myeloma
    Mark, Tomer M.
    Reid, Whitney
    Niesvizky, Ruben
    Gergis, Usama
    Pearse, Roger N.
    Mayer, Sebastian
    Coleman, Morton
    Feldman, Eric J.
    Shore, Tsiporah B.
    [J]. BLOOD, 2011, 118 (21) : 895 - 895
  • [7] Incidence and predictive factors of atrial fibrillation after ablation of typical atrial flutter
    Laurent, Valerie
    Fauchier, Laurent
    Pierre, Bertrand
    Grimard, Caroline
    Babuty, Dominique
    [J]. JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2009, 24 (02) : 119 - 125
  • [8] Incidence and predictive factors of atrial fibrillation after ablation of typical atrial flutter
    Valérie Laurent
    Laurent Fauchier
    Bertrand Pierre
    Caroline Grimard
    Dominique Babuty
    [J]. Journal of Interventional Cardiac Electrophysiology, 2009, 24 : 119 - 125
  • [9] Addition of Busulfan to Melphalan in conditioning of the autologous transplant of stem cells in multiple myeloma
    Stocker, Nicolas
    [J]. HEMATOLOGIE, 2019, 25 (03): : 1135 - 136
  • [10] Incidence and risk factors for symptomatic heart failure after catheter ablation of atrial fibrillation and atrial flutter
    Huang, Henry D.
    Waks, Jonathan W.
    Contreras-Valdes, Fernando M.
    Haffajee, Charles
    Buxton, Alfred E.
    Josephson, Mark E.
    [J]. EUROPACE, 2016, 18 (04): : 521 - 530
12345